Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

20052,507 citationsJournal Articlebronze Open Access

Authors

Among patients with a history of colorectal adenomas, the use of rofecoxib was associated with an increased cardiovascular risk.

Good health and well-being

Published in: New England Journal of Medicine

Volume 352, Issue 11, pp. 1092-1102

Field-Weighted Citation Impact: 236.87